Overview

Hair Regeneration in Androgenetic Alopecia

Status:
Active, not recruiting
Trial end date:
2023-11-30
Target enrollment:
Participant gender:
Summary
This clinical trial study aims to compare the effectiveness and safety of secretome from ADSCs with minoxidil in AGA cases, to provide future reference or standard in the application of cell-based therapy and its derivatives in AGA cases. The subject of this study is androgenetic alopecia population. The main questions it aims to answer are: - Is the secretome of ADSC's effective compared to minoxidil? - Is the secretome of ADSC's safe compared to minoxidil? - Is the combination of the secretome of ADSC's and minoxidil better in safety and effectiveness compared to secretome or minoxidil alone?
Phase:
N/A
Details
Lead Sponsor:
Dr. dr. Lili Legiawati, SpKK(K)
Collaborators:
Ministry of Education, Culture, Research, and Technology, Republic of Indonesia
PT. Kimia Farma (Persero) Tbk
Treatments:
Minoxidil